Introduction
Chlamydia trachomatis is recognised as one of the most prevalent sexually transmitted pathogen. Although genital infection with this organism is often low grade and chronic, it remains an important cause of PID and its sequelae.
Several non-cultural antigen detection techniques are now available for the diagnosis of genital chlamydial infection.' Evaluation in a high risk population is usually statistically favourable towards the new test with regard to the prediction value of a positive result, whereas the converse may well be the case in a low risk population. Only a few of the tests currently available incorporate a confirmatory test, which will reduce the possibility of false positive results. 2 We describe here the evaluation of a new enzyme immunoassay (EIA) (Northumbria Biologicals Ltd, UK) in high and low risk populations against a standard cell culture technique. Discrepant results were further analysed using direct immunofluorescence (DIF). A confirmatory test (blocking assay) was available for a proportion of the samples. Towards the end of this study, a blocking antibody became available. Only those samples which had sufficient material left to do the confirmatory test were available for the blocking assay. These included all the 12 copositive and 11 of 24 EIA positive-culture negative samples. All the co-positive samples were confirmed as positive by the blocking test. Four of the remaining 11 showed no drop in the O.D. with the blocking antibody, and the other seven gave a negative signal in both control and blocking assay wells. Only one of the three samples which was culture negative-EIA positive-DIF positive was available for reassay. This sample was not confirmed as positive using the blocking test. 
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